Community-based eye disease screening to prevent blindness
Official title: Village-Integrated Eye Worker Trial II (VIEW II) Extension
Funded at University of California, San Francisco · NIH-10934924 · Data updated 2026-11-12
This study is looking at how community eye screenings can help catch eye problems early, like glaucoma and age-related macular degeneration, in people living in Nepal, so they can get the care they need before it leads to blindness.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $1,448,874 |
| NIH project number | 1UG1EY036346-01 |
| Project ID | NIH-10934924 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living in resource-limited settings who are at risk for progressive eye diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration.
✕Less likely to help
Patients who do not reside in the targeted communities or who do not have risk factors for the eye diseases being screened may not benefit from this research.
What this research studies
This research focuses on preventing avoidable blindness in resource-limited settings by implementing community-based eye disease screening. It involves visual acuity assessments and advanced diagnostic techniques like optical coherence tomography (OCT) and intraocular pressure (IOP) measurements. Communities in Nepal are randomly assigned to receive either the screening intervention or no intervention, allowing researchers to evaluate the effectiveness of early detection and referral for conditions such as glaucoma and age-related macular degeneration. The project aims to identify cases before they lead to irreversible vision loss and improve overall community eye health.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of blindness caused by progressive eye diseases in underserved communities.
How similar studies have gone: Previous research has shown that community-based screening approaches can effectively reduce the prevalence of blindness in similar populations, indicating a promising avenue for this intervention.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Keenan, Jeremy David — University of California, San Francisco
- Study coordinator: Keenan, Jeremy David
Related research
Other NIH-funded projects on the same topics.
-
How cancer cells use exosomes to evade the immune system
This study is looking at how cancer cells use tiny bubbles called exosomes to hide proteins that can keep your immune system from fighting the tumor, and by figuring this out, the researchers hope to help doctors understand why some people respond well to cancer treatments while others don’t, ultimately aiming to creat
-
Reducing harm from smoking using electronic cigarettes
This study is looking at whether using electronic cigarettes can be a safer option for people who smoke traditional cigarettes, by comparing the health effects and exposure to harmful substances between the two.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Cutaneous opioid signals in skin inflammation
A mentor-identified clinician-researcher at UCSF is studying how natural skin opioids regulate itch and pain in inflammatory skin conditions like eczema and hidradenitis, with plans to map where these opioids come from and how they affect skin nerves.
-
Pooling international data to understand long-term bisphosphonate use and atypical femur fractures
This project combines large patient datasets from multiple countries to understand how long-term bisphosphonate use relates to rare hip and thigh bone fractures, helping doctors and patients make safer treatment choices.
-
Airway cell and immune cell talks in lung transplant failure
This grant tests how airway cells and immune cells interact to drive chronic rejection after lung transplant, with the goal of slowing or preventing scar-like damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.